This module is for enrolled MScPHM students. Enter your NUS email to begin.
Welcome! This is your first sign-in. Please create a password you will use to return to the course.
Please choose something you don't use for important accounts.
Welcome back! Enter your password to continue.
Forgotten it? Ask the MScPHM office to reset your access.
Your sign-in time, time spent, quiz results and any written answers are recorded for the course instructor to support your learning. By signing in you consent to this.
How cells grow, duplicate DNA, divide chromosomes, and how failures in these controls contribute to cancer and disease. This module builds on Module CB01 and goes a step deeper.
Start the modulePrecision health and medicine depends on understanding not only what genetic information cells contain, but how cells copy, monitor, divide, and sometimes mismanage that information.
Module CB01 gave you the molecules — DNA, RNA and protein. This module puts them in motion: the cell cycle is the regulated programme by which one cell becomes two, faithfully passing on its genome each time.
The same core process underlies an enormous range of normal and disease biology. As you read, notice how many of these you will meet again later in the MScPHM programme:
Growth and development, tissue renewal and repair, stem cells, immune-cell expansion during infection, wound healing, and reproduction all rely on controlled cell division.
Cancer, genomic instability, precision oncology, biomarker interpretation, flow cytometry, single-cell RNA-seq cell-cycle scoring, and drug targeting all trace back to how — and how well — cells run this cycle.
When you later see a tumour described as "highly proliferative", a Ki-67 score on a pathology report, a cell-cycle module in a single-cell dataset, or a drug called a "CDK4/6 inhibitor", you are looking at cell-cycle biology being read out as clinical information. This module is where those terms start to make sense.
The cell cycle is the ordered series of events by which a cell grows, copies its DNA, checks its work, and divides into two cells. It runs the same core steps in a defined order, over and over.
The cycle is not a passive clock. It is actively driven forward by rising and falling protein activity, and actively held back at several checkpoints until conditions are safe. Progress is committed at specific, largely irreversible transitions — which is exactly why control can fail in characteristic ways.
Genomics asks what variants a tumour carries; transcriptomics and single-cell methods ask what state its cells are in — and "which part of the cell cycle" is one of the most important states to get right. Cell-cycle biology is the bridge between a genome and an observable cellular behaviour.
Why is cancer better described as a failure of regulation than simply "cells growing fast"?
In this section
Before we watch cells divide, we need shared words for the things being divided. Many students confuse a few of these — so we will define them carefully and then draw them.
| Term | Plain meaning |
|---|---|
| Cell | The basic unit of life; a membrane-bounded compartment that, in eukaryotes, holds a nucleus. |
| Nucleus | The membrane-bounded compartment that houses the genome in eukaryotic cells. |
| DNA | The double-stranded molecule that stores genetic information (Module CB01). |
| Chromatin | DNA wrapped around histone proteins; the "unpacked", working form of the genome. |
| Chromosome | A single long DNA molecule with its proteins; visibly condensed during division. |
| Homologous chromosomes | A matching pair (one from each parent) carrying the same genes, not necessarily the same alleles. |
| Sister chromatids | The two identical copies of one chromosome after DNA replication, joined together. |
| Centromere | The constricted region where sister chromatids are held together and the spindle attaches. |
| Kinetochore | A protein machine built on the centromere that grips spindle microtubules. |
| Centrosome | The main organising centre for spindle microtubules; duplicated once per cycle. |
| Spindle microtubules | Dynamic protein cables that attach to chromosomes and pull them apart. |
| Cytokinesis | The physical splitting of one cell into two, after the nucleus has divided. |
| Somatic cell | Any ordinary body cell (not a sperm or egg); divides by mitosis. |
| Germ cell | A cell in the reproductive lineage that can give rise to gametes. |
| Gamete | A sperm or egg; haploid, made by meiosis. |
| Zygote | The diploid cell formed when two gametes fuse at fertilisation. |
| Haploid (n) | One set of chromosomes (23 in humans) — as in gametes. |
| Diploid (2n) | Two sets of chromosomes (46 in humans) — as in somatic cells. |
| Aneuploid | An abnormal chromosome number (e.g. 45 or 47), often from a segregation error. |
The single most useful picture in this module: how one chromosome becomes two sister chromatids, and how that differs from a pair of homologues.
Colour is used only to tell the two homologues apart (teal vs amber, both distinguishable in common colour-vision types); shape and labels carry the meaning, so the figure remains readable without colour.
Think of a chromosome as a file. Replication in S phase makes an exact copy kept alongside the original — the two sister chromatids — still bundled under one name until division splits them into separate cells. A homologous pair is more like two independent files with the same schema (the same genes) but possibly different contents (different alleles).
Where the analogy breaks: files do not physically attach to each other, and a cell cannot simply "diff" its chromatids — it relies on the mechanical and molecular checks we meet later.
An unreplicated chromosome is one chromatid. After S phase it is two identical sister chromatids joined at the centromere. Homologous chromosomes are a matched pair — one inherited from each parent.
The centromere is defined less by its DNA sequence than by a special histone (CENP-A) that marks where the kinetochore assembles. Cohesin protein rings hold sister chromatids together from S phase until the cell is certain every chromosome is correctly attached to the spindle.
Karyotyping, copy-number analysis, and aneuploidy calling in tumour genomes all depend on this vocabulary. "Gain of chromosome 8" or "loss of 17p" only means something once you can picture the objects being counted.
A cell in G2 has "twice as much DNA" as it did in G1, but the same number of chromosomes. How can both be true?
In this section
The cell cycle is usually drawn as a loop with four main phases. Three of them — G1, S and G2 — together make up interphase. The fourth, M phase (mitosis), is when the duplicated genome is actually divided, and is normally followed immediately by cytokinesis. Cells that are not actively cycling sit in a state called G0.
Interphase is not a rest period. During interphase the cell is growing, running its normal metabolism, doubling its organelles, and — in S phase — copying its entire genome. "Inter" just means "between divisions", not "idle".
Read the cycle as a pipeline with ordered stages and gates: G1 provisions and decides whether to start the job; S executes the expensive copy step; G2 verifies the copy; M partitions the result; cytokinesis commits two outputs. Each gate can hold the pipeline until preconditions are met.
Where the analogy breaks: there is no central scheduler issuing commands. Progression emerges from the rising and falling concentrations of proteins and their chemical modifications — a system we open up in the next section.
The wheel below is interactive. Select any phase — including the resting state G0 and the final split, cytokinesis — to see what the cell is doing, what is being checked, and why it matters clinically.
Tap or click a segment · use Tab + Enter to select with a keyboard
Choose any segment of the wheel to read a plain-language summary, the key molecular events, the main risk if control fails, and its precision-health relevance.
| Phase | Main purpose | Key events | Checkpoint logic | Clinical relevance |
|---|---|---|---|---|
| G0 | Resting / non-dividing | Normal function; may be reversible (quiescent) or permanent (senescent, terminally differentiated). | Entry requires a growth signal to leave G0. | Most adult cells are in G0; many neurons and muscle cells stay there for life. |
| G1 | Grow & decide | Cell grows, makes proteins, senses nutrients and signals; commits at the restriction point. | G1/S checkpoint: is the cell big enough, fed, and undamaged? | Where most oncogenic "go" signals and CDK4/6 inhibitors act. |
| S | Copy the genome | DNA replication; each chromosome becomes two sister chromatids; histones duplicated. | Intra-S checkpoint watches for replication stress. | Replication stress is a hallmark of many cancers and a drug target. |
| G2 | Check the copy | Continued growth; verifies replication is complete and repairs DNA damage. | G2/M checkpoint: is DNA fully and correctly copied? | Loss of G2/M control lets damaged cells enter mitosis. |
| M | Divide the nucleus | Chromosomes condense, align, and sister chromatids separate to opposite poles. | Spindle assembly checkpoint: is every chromosome correctly attached? | Target of antimitotic chemotherapy (e.g. taxanes). |
| Cytokinesis | Split the cell | An actomyosin ring pinches the cytoplasm into two daughter cells. | Coupled to correct mitotic exit. | Failure can produce a single cell with double the chromosomes (a route to instability). |
Watch · ~3 min
A short visual introduction to interphase, mitosis, and cytokinesis, useful before the deeper sections.
As you watch: identify which parts of interphase are preparation, which are copying, and which are quality control.
Source & copyright: © Encyclopædia Britannica, Inc. Linked, not embedded. Opens in a new tab.
The order is G1 → S → G2 → M, then two daughter cells. G1, S and G2 make up interphase; M is division. Cells that stop cycling wait in G0.
The lengths of the phases vary enormously by cell type. G1 is the most variable and is where cells integrate signals about whether to divide at all. S phase length is relatively fixed; M phase is usually the shortest — often under an hour in a cycle that may last a day.
Single-cell RNA-seq can assign each cell a likely cycle phase from the genes it is expressing. This is powerful — but also a confounder, because strongly cycling cells can cluster together by phase rather than by cell type. We return to this in Section 12.
Two tissues have the same number of cells, but one has far more cells in S and G2/M. What does that tell you, and why might it matter clinically?
In this section
Nothing tells the cell "now do S phase". Instead, the cycle is driven by a family of enzymes whose activity rises and falls in a set order. The engines are cyclin-dependent kinases (CDKs) — enzymes that add phosphate groups to target proteins. A CDK is only active when bound to a partner protein called a cyclin. Cyclins are made and destroyed on schedule, so cyclin availability times CDK activity.
A regulatory protein whose level rises and falls across the cycle. Different cyclins mark different phases.
A kinase that is inactive on its own. Bound to its cyclin, it phosphorylates targets that push the cycle forward.
A brake protein (e.g. p21, p16) that blocks cyclin–CDK activity to hold the cycle.
Ubiquitin ligases (SCF, APC/C) tag specific proteins for destruction, making transitions sharp and one-way.
Two things make transitions decisive rather than gradual. First, phosphorylation switches target proteins on or off quickly. Second, targeted protein degradation destroys key regulators so a step cannot easily run backwards. The SCF complex mainly drives the G1→S transition; the APC/C complex drives the exit from mitosis and the destruction of mitotic cyclins.
The cell cycle behaves like a regulated state machine — but the states are held and switched by biochemical concentrations, phosphorylation events, degradation, and feedback loops rather than by software instructions. Positive feedback makes each transition snap cleanly (like a Schmitt trigger); targeted degradation makes it hard to run backwards, giving the cycle its one-way, ratchet-like quality.
Where the analogy breaks: there is no discrete clock, no instruction pointer, and no clean separation between "logic" and "hardware". The same molecules that carry the signal also do the work, values are noisy analog concentrations, and there is no external controller — the system regulates itself.
Each cyclin–CDK pair peaks at a different point, and hands over to the next. This staggered relay is what gives the cycle its order.
Interactive and schematic. Real activity profiles overlap and are shaped by feedback; scrub to see which complex dominates each phase.
The restriction point in late G1 is the cell's point of no return: past it, the cell will usually complete the cycle even if growth signals disappear. Two circuits govern it.
In the RB–E2F pathway, the retinoblastoma protein RB normally holds back the transcription factor E2F, which switches on S-phase genes. When Cyclin D–CDK4/6 (and then Cyclin E–CDK2) phosphorylate RB, RB releases E2F, and the cell commits to replication. In the p53–p21 pathway, DNA damage activates p53, which switches on the CDK inhibitor p21, applying a brake so the cell pauses to repair, or — if damage is severe — exits permanently.
"→" means activates/promotes; "⊣" means inhibits. The balance of go and stop inputs decides whether the cell crosses the restriction point.
| Key player | Type | Main role | Phase / checkpoint | If disrupted |
|---|---|---|---|---|
| Cyclin D | Cyclin | Relays mitogen signals into the cycle | Early–mid G1 | Amplification drives unchecked G1/S entry (e.g. some breast cancers). |
| CDK4/6 | Kinase | With Cyclin D, begins RB phosphorylation | G1 | Over-activation bypasses the restriction point; target of CDK4/6 inhibitors. |
| Cyclin E | Cyclin | Completes RB phosphorylation; triggers S entry | G1→S | Over-expression causes premature, error-prone replication. |
| CDK2 | Kinase | With Cyclin E then A, drives S phase | S | Dysregulation contributes to replication stress. |
| Cyclin A | Cyclin | Supports DNA replication and entry to M | S–G2 | Mis-timing disturbs replication and mitotic entry. |
| Cyclin B | Cyclin | With CDK1, triggers mitosis | G2→M | Its scheduled destruction (APC/C) is required to exit mitosis. |
| CDK1 | Kinase | The master mitotic kinase | M | Mis-regulation causes premature or failed mitosis. |
| RB | Tumour suppressor | Restrains E2F until commitment | Restriction point | Loss removes the G1/S brake — a common cancer event. |
| E2F | Transcription factor | Switches on S-phase genes | G1→S | Unrestrained E2F forces inappropriate proliferation. |
| p53 | Tumour suppressor | "Guardian of the genome"; halts or kills damaged cells | Multiple checkpoints | Loss (TP53 mutation) removes a major damage response; very common in cancer. |
| p21 | CDK inhibitor | Applies the brake downstream of p53 | G1/S, G2/M | Loss weakens damage-induced arrest. |
| p16 (CDKN2A) | CDK inhibitor | Blocks CDK4/6 | G1 | Frequent loss releases the CDK4/6 brake. |
| SCF | Ubiquitin ligase | Degrades G1/S regulators | G1→S | Sharpens the transition; dysregulation blurs it. |
| APC/C | Ubiquitin ligase | Degrades securin and mitotic cyclins | M / exit | Required for chromatid separation and mitotic exit. |
| Ki-67 | Marker protein | Present in cycling cells, absent in G0 | All active phases | Used clinically as a proliferation marker (Section 12). |
Watch · animated overview
An animated overview of cell-cycle progression and its regulation. Verify title before publication
As you watch: separate the phases of the cycle from the regulatory proteins that drive the transitions between them.
Source & copyright: © Nucleus Medical Media / Nucleus Biology. Linked, not embedded. Confirm the exact current title before final publication.
CDK enzymes drive the cycle but only work when bound to a cyclin. Different cyclin–CDK pairs peak in different phases. Brakes (CDK inhibitors like p21, p16) and targeted destruction (SCF, APC/C) keep the order correct and one-way.
The 2001 Nobel Prize in Physiology or Medicine went to Leland Hartwell, Tim Hunt, and Paul Nurse for discovering the cyclins and CDKs that control this system — work that reframed the cycle as a controllable molecular circuit and opened the door to today's CDK-targeted cancer drugs.
Many of the genes in tumour "driver" lists — CCND1 (Cyclin D), CDK4, RB1, CDKN2A (p16), TP53 — are simply the parts of this circuit. Reading a cancer genome is often reading which brakes were lost and which accelerators were amplified.
Why does destroying a protein (rather than just switching it off) help make a cell-cycle transition sharp and irreversible?
In this section
Checkpoints are not physical gates — they are signalling circuits that detect a problem and hold the cycle until it is fixed. Each sits just before an expensive or irreversible step, so the cell "checks before it commits". Three outcomes are possible at a checkpoint: pause and repair, proceed, or — if damage is too great — exit permanently by senescence or programmed cell death (apoptosis).
Play or drag to send a cell around the cycle. It pauses at each checkpoint, which turns green as its conditions are met. The narration explains what each gate checks — and what happens if a check fails.
Schematic. Checkpoints are signalling circuits, not physical gates; a passing cycle is shown here — any check can instead pause, repair, or trigger permanent exit.
A checkpoint is an assertion before a commit: verify a precondition, and if it fails, block progress and raise a repair routine rather than shipping a corrupt build.
Where the analogy breaks: the "assertion" is itself a slow, noisy molecular process that can be overwhelmed, silenced by mutation, or fooled — which is precisely how cancers escape it.
Before spending energy on replication, the cell asks: are growth signals present, are nutrients and energy sufficient, and is the DNA undamaged? The RB–E2F switch and Cyclin D–CDK4/6 / Cyclin E–CDK2 drive commitment; the p53–p21 response can veto it if damage is found.
Replication does not always run smoothly. When forks stall — from damage, tight DNA structures, or shortage of building blocks — the cell experiences replication stress. The ATR–CHK1 pathway senses stalled forks, slows new origin firing, stabilises the forks, and buys time, so the cell avoids finishing S phase with incomplete or damaged DNA.
Many cancers already run with high replication stress. Drugs that inhibit ATR, CHK1 or WEE1 push these stressed cells past a tolerable limit — an introductory example of synthetic lethality, where a therapy is lethal only in the context of a specific pre-existing defect.
Before mitosis, the cell verifies that replication is complete and DNA damage is repaired. The mitotic engine Cyclin B–CDK1 is held inactive by inhibitory phosphorylation from WEE1; the phosphatase CDC25 removes those marks to fire mitosis. If damage is detected, the checkpoint keeps CDK1 off, and the cell repairs, arrests, or — if needed — undergoes apoptosis.
The last gate, in mitosis, guards chromosome segregation. The cell must not separate sister chromatids until every kinetochore is attached to spindle microtubules from the correct pole (bi-orientation) and under proper tension. Unattached kinetochores keep the checkpoint "on" via MAD and BUB proteins (e.g. MAD2, BUBR1). Once all are attached, the APC/C is activated: it destroys securin, freeing the protease separase, which cleaves cohesin — the glue holding sister chromatids together — allowing them to separate.
A single unattached kinetochore is enough to keep the whole checkpoint on — a striking example of biological caution before an irreversible step.
For each scenario, decide what a healthy checkpoint should do. Pick an option to get immediate feedback. There is often a "best" answer, and the feedback explains why.
1 · DNA damage detected in G1.
before the cell has copied anything
2 · Replication forks have stalled in S phase.
replication stress detected
3 · DNA replication is incomplete in G2.
some regions not yet copied
4 · One kinetochore is unattached in metaphase.
chromosomes otherwise aligned
5 · All chromosomes are bi-oriented and under tension.
metaphase complete
Checkpoints check before big steps: G1/S before copying, intra-S during copying, G2/M before dividing, and the spindle checkpoint before pulling chromosomes apart. If something is wrong, the cell pauses, repairs, or dies.
Checkpoints are enforced by kinase cascades. ATM mainly senses double-strand breaks and signals through CHK2; ATR mainly senses single-stranded DNA and replication stress and signals through CHK1. Both ultimately restrain the CDKs — either by activating p53–p21 or by keeping inhibitory phosphates on CDK1.
BRCA1/2 defects impair repair of double-strand breaks, raising reliance on other pathways — the basis for PARP-inhibitor therapy (Section 12). Checkpoint and repair genes are among the most clinically actionable in precision oncology.
Why must a single unattached kinetochore be able to halt the entire cell, rather than the cell proceeding "on average"?
In this section
In Module CB01 you met DNA as an antiparallel double helix that can be copied by base-pairing. S phase is when that copying actually happens for the whole genome — and the cell's hardest constraint is captured in one rule: every stretch of DNA must be replicated exactly once per cycle. Copy a region twice and you create extra, unstable DNA; miss a region and daughter cells inherit an incomplete genome.
Think of replication as copying a master database where the copy must be complete and each record written exactly once. The cell enforces "exactly once" by splitting the job into two time-locked steps: it lays down permits in one phase and can only spend each permit in the next.
Where the analogy breaks: there is no transaction log to roll back to. The safeguards are chemical states on the DNA itself, and if they fail the error is baked into the genome.
The trick is to separate licensing from firing. In G1 (low CDK activity), the origin recognition complex (ORC) marks starting points, and CDC6 and CDT1 help load the MCM helicase onto the DNA — a permit, but not yet an active machine. When S phase begins (rising CDK activity), origins fire: the helicases activate, unwind the DNA, and replication forks move outward in both directions. Crucially, the same high-CDK state that fires origins also blocks any new licensing, so origins cannot be re-loaded and fired twice in one cycle. This prevents re-replication.
Two steps, two phases: load the permit in G1, spend it in S.
Schematic. Real origins are numerous and fire on a staggered schedule; the key idea is the enforced separation of licensing (G1) from firing (S).
When forks meet trouble, the intra-S checkpoint and the wider DNA damage response step in (Section 4). Persistent replication stress, unrepaired breaks, or under-replicated regions carried into mitosis are major sources of genome instability.
Why would re-replicating part of the genome be dangerous?
DNA is copied in S phase. Origins are "licensed" in G1 and "fired" in S, and re-licensing is blocked during S — so each piece is copied exactly once.
Licensing depends on low CDK activity; firing and the block on re-licensing depend on high CDK activity. Because the same signal that fires origins also prevents new loading, the cell couples "start copying" to "no second copy" automatically.
Replication errors and under-replication feed directly into copy-number variation, chromosomal instability, and the branching tumour evolution you will study in cancer genomics — where a tumour's history is read from the copy-number scars left in its genome.
In this section
Mitosis is nuclear division — the process that shares one duplicated genome equally between two nuclei. It is normally followed immediately by cytokinesis, which splits the cytoplasm into two cells. The two are separate steps, and confusing them is one of the most common errors in this topic.
Drag the timeline or press play to move through mitosis continuously. Pause anywhere — the narration updates with each phase.
Schematic, showing two chromosomes (teal and amber) for clarity; a human cell has 46. Motion respects your reduced-motion setting.
| Stage | Chromosomes | Nuclear envelope | Spindle / centrosomes | If it failed |
|---|---|---|---|---|
| Prophase | Condense into visible X-shaped pairs of sister chromatids | Still intact | Centrosomes separate; spindle begins to form | Tangled, uncondensed chromosomes are hard to move cleanly |
| Prometaphase | Fully condensed; kinetochores captured | Breaks down | Microtubules search for and attach kinetochores | Mis-attachments risk mis-segregation |
| Metaphase | Aligned at the metaphase plate (cell equator) | Absent | Bi-oriented; under tension from both poles | Un-aligned chromosomes trigger the spindle checkpoint |
| Anaphase | Sister chromatids separate and move to opposite poles | Absent | Anaphase A: kinetochore fibres shorten · Anaphase B: poles move apart | Lagging chromatids can be lost or trapped |
| Telophase | Arrive at poles; begin to decondense | Re-forms around each set | Spindle disassembles | Failure to re-form nuclei disrupts the daughter cells |
| Cytokinesis | Two complete sets, one per forming cell | Two nuclei present | Actomyosin ring pinches at the midbody | Failure yields one cell with double the chromosomes |
Two mechanical details are worth naming. In anaphase, chromatids are pulled apart in two ways at a simple level: anaphase A, where the fibres attached to kinetochores shorten, and anaphase B, where the whole spindle elongates and the poles move further apart. In cytokinesis, a cleavage furrow forms as an actomyosin contractile ring tightens like a drawstring; the last connection, the midbody, is finally severed to give two genetically similar daughter cells.
Watch · cell division
A professional visual explanation of cell division: chromosome duplication, mitosis, cytokinesis, and daughter-cell formation.
As you watch: separate chromosome movement (mitosis) from the splitting of the cell (cytokinesis).
Source & copyright: © Encyclopædia Britannica, Inc. Linked, not embedded. Opens in a new tab.
Mitosis divides the nucleus in five stages — prophase, prometaphase, metaphase, anaphase, telophase — and cytokinesis then divides the cell. The result is two cells that are genetically similar to the parent.
The metaphase plate is not a physical structure but the plane where balanced pulling forces bring chromosomes to rest. Alignment is dynamic: chromosomes oscillate until every kinetochore is correctly attached and the spindle checkpoint is satisfied.
Pathologists count cells "caught" in mitosis (the mitotic index) as a measure of how fast a tumour divides — one of the oldest quantitative links between cell-cycle biology and clinical grading (Section 12).
A drug blocks cytokinesis but not mitosis. What kind of cell would you expect to find, and why could that be dangerous?
In this section
When the safeguards of the last few sections break down, cells can accumulate and pass on serious genomic errors. A cascade often begins with DNA damage accumulation and checkpoint failure: damage that should have paused the cycle is ignored, repair fails, and chromosomes are mis-handled in mitosis.
The consequences have names you will meet again. Aneuploidy is an abnormal chromosome number. Chromosomal instability (CIN) is an ongoing high rate of gaining and losing chromosomes. Lagging chromosomes that fail to reach a pole can be packaged into small extra nuclei called micronuclei, whose fragile envelopes can rupture and trigger catastrophic, localised shattering and reassembly of a chromosome — chromothripsis (an advanced idea, introduced here only by name). Separately, centrosome amplification (too many spindle poles) risks a multipolar spindle that mis-distributes chromosomes.
A schematic of the vicious cycle — and why selection, not a single error, is what produces a tumour.
One failed mitosis does not automatically cause cancer. Cancer usually develops through the multi-step accumulation and selection of genetic, epigenetic and cellular changes that disrupt proliferation control, DNA repair, apoptosis, senescence, and the normal constraints tissues place on their cells. Instability raises the odds; it is not a switch.
Cancers frequently show recognisable lesions in the circuitry from earlier sections. Common examples include TP53 loss (removing a major damage response), RB pathway disruption, Cyclin D / CDK4/6 activation, MYC-driven proliferation, BRCA1/2-related genome-maintenance defects, spindle checkpoint defects, and, where telomeres erode, a period of telomere crisis that can itself drive rearrangements.
Because tumours depend on this machinery, the machinery is druggable and measurable:
When checkpoints and repair fail, cells can gain or lose chromosomes (aneuploidy) and become genomically unstable. Over many steps and under selection, this can contribute to cancer — but it is not a single event.
Instability is double-edged for the tumour: it generates the diversity that fuels adaptation and drug resistance, but too much instability can be lethal to a cell. Many tumours sit at a tolerated level of instability — a vulnerability some therapies aim to tip over.
This is the conceptual heart of precision oncology: match a therapy to a tumour's specific defect. Reading which cell-cycle and repair genes are broken is how a molecular tumour board reasons about treatment options.
Why can genomic instability be described as both an advantage and a liability for a tumour?
In this section
Meiosis is a specialised division programme in germ cells that makes haploid gametes (sperm and eggs). Its purpose is fourfold: reduce the chromosome number from diploid to haploid, produce gametes, generate genetic diversity, and, by halving before fertilisation, maintain the species chromosome number across generations (two haploid gametes fuse to restore the diploid state).
Like mitosis, meiosis is preceded by a premeiotic S phase that replicates the DNA once. But then come two divisions. Meiosis I is reductional: it separates homologous chromosomes, halving the chromosome number. Meiosis II is equational: it separates sister chromatids, like mitosis. The result is four haploid cells.
The single hardest idea here: meiosis I separates homologous chromosomes; meiosis II separates sister chromatids. Mitosis only ever does the second of these. Keep asking "what is being pulled apart?" at each step.
Prophase I is unusually long and important, because this is where homologues pair and exchange DNA. The five substages, explained plainly:
| Substage | What happens |
|---|---|
| Leptotene | Chromosomes begin to condense and become visible as thin threads. |
| Zygotene | Homologues start to pair up (synapsis), zipping together along their length. |
| Pachytene | Pairing is complete; crossing over exchanges segments between homologues. |
| Diplotene | Homologues begin to separate but stay joined at crossover points (chiasmata). |
| Diakinesis | Chromosomes fully condense; the cell prepares for metaphase I. |
The scaffold that zips homologues together is the synaptonemal complex (named here at a conceptual level). It holds the pair in register so that crossing over — physical recombination between homologues — can occur accurately.
Prophase I (pairing, crossing over) → Metaphase I (homologous pairs line up; each pair assorts independently) → Anaphase I (homologues separate; sister chromatids stay together) → Telophase I & cytokinesis (two haploid cells, each chromosome still two chromatids).
Prophase II → Metaphase II (chromosomes line up singly) → Anaphase II (sister chromatids finally separate) → Telophase II & cytokinesis (four genetically distinct haploid gametes).
Two mechanisms make gametes genetically unique. Independent assortment at metaphase I means each homologous pair orients randomly, so maternal and paternal chromosomes are shuffled between gametes. Crossing over (recombination) further mixes alleles within chromosomes. Both are covered further in Section 9.
Drag or play through both divisions. Watch the chromosome number halve at anaphase I, and the sister chromatids separate only in meiosis II.
Schematic, showing one homologous pair (teal maternal, amber paternal); a human germ cell has 23 pairs. Motion respects your reduced-motion setting.
Reference · reduction division
A reference-style explanation of meiosis, reduction division, and gamete formation.
As you read: identify exactly where the chromosome number is reduced.
Source & copyright: © Encyclopædia Britannica, Inc. Linked, not embedded. Opens in a new tab.
Watch · animated
An animated explanation of meiosis and gamete production.
As you watch: compare the outcome of meiosis I with the outcome of meiosis II.
Source & copyright: © Nucleus Medical Media / Nucleus Biology. Linked, not embedded. Opens in a new tab.
Meiosis copies the DNA once and then divides twice. Meiosis I separates homologous chromosomes (halving the number); meiosis II separates sister chromatids. The result is four haploid, genetically distinct gametes.
Because homologues must pair and recombine, meiosis I is where most chromosome-segregation errors occur — and these errors, unlike most mitotic ones, are inherited by the offspring rather than confined to one tissue.
Recombination during meiosis is what makes linkage and genome-wide association possible: because nearby variants tend to be inherited together, meiosis shapes the very structure that statistical genetics exploits.
At the end of meiosis I, a cell is haploid but each chromosome still has two chromatids. Why is a second division needed at all?
In this section
During pachytene of prophase I, paired homologous chromosomes undergo synapsis and then recombination: they physically break and rejoin, exchanging DNA segments. The points of exchange, visible as chiasmata, hold the homologues together until anaphase I. The result is recombinant chromatids that carry a new mix of maternal and paternal alleles — a major source of genetic diversity.
Play through prophase I: the homologues pair, form a chiasma, physically swap segments, and separate as recombinant chromatids.
Crossing over interacts with linkage (introduced here): alleles that sit close together on a chromosome are separated by crossing over only rarely, so they tend to be inherited together, while distant alleles are shuffled more freely. This is why crossing over is not random noise but a controlled process — too little, and homologues may fail to separate correctly; too much or mis-placed, and harmful rearrangements can result.
Watch · focused explainer
A focused explanation of crossing over and how it builds genetic diversity.
As you watch: track the difference between sister chromatids and homologous chromosomes.
Source & copyright: © Bio Scholar. Linked, not embedded. Opens in a new tab.
In meiosis I, paired homologues swap matching segments of DNA. This creates chromatids with new allele combinations, so each gamete — and each offspring — is genetically unique.
Crossovers are not just for diversity: at least one crossover per homologous pair is usually required to keep the pair connected until anaphase I. A pair with no crossover is prone to mis-segregate.
The rate of recombination varies across the genome, creating "recombination hotspots". These patterns underpin genetic mapping, haplotype structure, and how association studies pinpoint disease loci.
Why does a homologous pair with no crossover risk segregating incorrectly in meiosis I?
In this section
The central error of meiosis is nondisjunction — a failure of chromosomes to separate correctly, either in meiosis I (homologues fail to separate) or meiosis II (sister chromatids fail to separate). The result is an aneuploid gamete with one too many or one too few chromosomes. After fertilisation, this produces a trisomy (three copies of a chromosome) or a monosomy (one copy).
The consequences are chiefly reproductive and developmental: miscarriage (many aneuploidies are not viable), developmental disorders, and infertility. There is a well-established age-related risk, especially in oogenesis, because eggs remain arrested in meiosis for many years before completing division, and the cohesion holding chromosomes together weakens over time. Other contributors include errors in recombination, failure of chromosome pairing, and inherited germline chromosomal rearrangements.
Meiosis failure is not usually described as a direct cause of most adult cancers in the way that somatic cell-cycle checkpoint failure is. Its major clinical consequences are reproductive and developmental. However, meiosis illustrates the core principles of chromosome segregation and genome stability that are highly relevant to cancer.
So why study meiosis in a precision-medicine course? Because the principles transfer. Nondisjunction, cohesion, tension-sensing, and correct bi-orientation are exactly the mechanisms whose somatic failure drives the aneuploidy and chromosomal instability of tumours (Section 7). Meiosis is a clean teaching system for machinery that also matters in cancer — while its direct clinical footprint is in fertility, prenatal testing, and reproductive genomics.
If chromosomes fail to separate in meiosis (nondisjunction), gametes end up with the wrong number of chromosomes. This can cause miscarriage, developmental conditions, or infertility — mainly reproductive effects, not adult cancer.
Most human aneuploidies arise from errors in maternal meiosis I, and their frequency rises with maternal age — a pattern linked to the very long meiotic arrest of the oocyte and gradual loss of chromosome cohesion.
Prenatal screening, non-invasive prenatal testing, and preimplantation genetic testing all detect aneuploidy that originates in meiosis. The same counting logic you learned for tumour karyotypes applies to embryos.
Why are meiotic errors "inherited" by an entire organism, whereas most mitotic errors affect only one tissue or clone?
In this section
Mitosis and meiosis share chromosomes, spindles, cohesin, and checkpoints — but put them to different ends. The table lines them up side by side.
| Feature | Mitosis | Meiosis |
|---|---|---|
| Cell type | Somatic cells | Germline cells |
| Purpose | Growth, repair, replacement | Gamete production |
| DNA replication | Once before division | Once before meiosis I |
| Number of divisions | One | Two |
| Homologue pairing | No | Yes, during prophase I |
| Crossing over | Usually no | Yes |
| Chromosome number | Maintained | Halved |
| Daughter cells | Two | Four |
| Genetic similarity | Usually genetically similar | Genetically distinct |
| Clinical failure | Cancer, aneuploidy, tissue dysfunction | Infertility, miscarriage, trisomy, monosomy |
Classify each statement. Some belong to both processes — read carefully. You get immediate feedback with a short reason.
Produces two daughter cells.
Produces four haploid cells.
Used for tissue repair.
Used for gamete production.
Homologous chromosomes pair.
Sister chromatids separate.
Crossing over occurs.
Chromosome number is maintained.
Chromosome number is halved.
Preceded by one round of DNA replication.
Watch · side by side
A side-by-side comparison of mitosis and meiosis.
As you watch: focus on the number of divisions, the chromosome number, and the genetic similarity of the daughter cells.
Source & copyright: © Nucleus Medical Media / Nucleus Biology. Linked, not embedded. Opens in a new tab.
Watch · consolidation
A medical-animation-style comparison of the two forms of cell division.
Use this as a consolidation resource after completing the comparison table above.
Source & copyright: © Nucleus Medical Media. Linked, not embedded. Opens in a new tab.
Both mitosis and meiosis II separate sister chromatids. What single earlier event makes their outcomes so different?
In this section
Everything in this module becomes clinical the moment we measure it. How fast a tumour proliferates, how stable its genome is, and which parts of the cycle its cells occupy all feed into diagnosis, prognosis, and therapy choice.
Ki-67 is present in cycling cells and absent in G0, so the Ki-67 index estimates the fraction of dividing cells. With tumour grade and mitotic index, it helps gauge how aggressive a tumour is.
Flow cytometry measures DNA per cell, revealing how many cells are in G0/G1 (2N), S (between), and G2/M (4N) — a direct readout of cycle distribution.
Cell-cycle signatures and single-cell RNA-seq cell-cycle scoring infer phase from gene expression — useful, but a known confounder that can cluster cells by phase rather than by true type.
Chromosomal instability is itself a tumour feature; cancer genome instability shapes evolution, heterogeneity, and resistance.
On the treatment side, the levers are the ones you have already met: CDK4/6 inhibitors restore G1 control; DNA damage response targeting (ATR/CHK1/WEE1) and PARP inhibitors exploit repair and replication vulnerabilities; and cell-cycle readouts support patient stratification and biomarkers. Beyond oncology, the same counting logic underpins fertility, prenatal testing, and reproductive genomics.
Flow cytometry stains DNA and counts cells at each DNA level. Cells in G0/G1 have 2N DNA; cells in G2/M have 4N (they have replicated); cells in S phase fall in between. Toggle between two samples and answer the questions.
1 · Which population is mostly non-dividing or in G0/G1?
2 · Which sample has more cells in S phase?
3 · Which sample appears more proliferative?
4 · Why can this matter in cancer biology?
In single-cell RNA-seq, strongly cycling cells can cluster together because they are cycling, masking their true identity. Distinguishing genuine biological cell states from cell-cycle-driven clustering — often by "regressing out" cycle signals — is a routine and important step. The cell cycle is both signal and noise.
Doctors and researchers measure how much cells are dividing (Ki-67, mitotic index, flow cytometry) and use that to judge tumours and choose treatments. DNA-content histograms show how many cells are in each phase.
DNA-content histograms can also reveal aneuploid populations as extra peaks at non-standard DNA amounts — a cytometric clue to chromosomal instability that complements sequencing and karyotyping.
This section is the payoff: the molecules from Module CB01 and the machinery from this module reappear as the biomarkers, drug targets, and analysis choices you will use throughout the MScPHM programme.
Two tumours have similar mutations but very different Ki-67 indices. Why might that change how they are treated?
A set of hands-on activities to consolidate the module. Nothing is recorded; use them as often as you like.
Match each event to the phase where it happens, then check your answers.
Decide whether the cell should proceed, pause and repair, trigger apoptosis/senescence, or block anaphase. This activity lives in Section 4 · Checkpoints — revisit it to test yourself.
Put the stages of mitosis in the correct order using the arrows, then check.
Order these meiosis events from first to last, then check.
Two more activities live earlier in the module: the classify game in Section 11 (mitosis, meiosis, or both) and the DNA-content histogram in Section 12. Revisit them to complete your practice.
Correction: Interphase includes active growth, DNA replication, and preparation for division. Only the shortest part — mitosis — is division itself.
Correction: A replicated chromosome contains two sister chromatids joined at the centromere; before replication it is a single chromatid.
Correction: Mitosis divides the nucleus; cytokinesis divides the whole cell. They are separate, and either can fail independently.
Correction: Cancer involves dysregulated proliferation, evasion of cell death, genome-maintenance defects, tissue invasion, and selection over many steps — not speed alone.
Correction: Many errors trigger arrest, repair, apoptosis, senescence, or cell death. Instability raises risk; it is not an automatic switch.
Correction: Meiotic failure mainly affects reproduction and development; somatic cell-cycle dysregulation is more central to most adult cancers.
Correction: Mitosis usually preserves genetic similarity; meiosis generates diversity through crossing over and independent assortment.
Fifteen questions across the module. Pick your answers, then check for feedback that explains the reasoning. Nothing is recorded.